81 studies found for:    vaccine adverse reactions | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
vaccine adverse reactions | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants
Condition: Encephalitis
Interventions: Biological: 0.5ml experimental vaccine on day 0,7 Vero cell-derived inactivated Japanese Encephalitis vaccine;   Biological: 0.5ml experimental vaccine on day 0,28 Vero cell-derived inactivated Japanese Encephalitis vaccine;   Biological: 0.5ml active comparator vaccine on day 0,7 inactivated freeze-dried Japanese Encephalitis vaccine(Vero cell)
2 Not yet recruiting A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China
Condition: Influenza
Intervention: Biological: inactivated quadrivalent influenza vaccine (split virion)
3 Not yet recruiting Hepatitis B Vaccination in Infants
Conditions: Meningococcal Disease;   Pneumococcal Disease;   Haemophilus Influenzae Serotype b Disease;   Diphtheria, Tetanus and Pertussis;   Hepatitis b
Interventions: Biological: Menjugate;   Biological: Menitorix;   Biological: NeisVac-C
4 Not yet recruiting Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine
Condition: Condylomata Acuminata
Interventions: Biological: low dosage HPV Vaccine;   Biological: medium dosage HPV Vaccine;   Biological: high dosage HPV Vaccine;   Biological: Aluminium Adjuvant
5 Not yet recruiting The Safety Research of Freeze-dried Rabies Vaccine(MRC-5 Cell) in Chinese Humans
Conditions: Rabies;   Healthy
Interventions: Biological: 2.5IU/ml in rabies vaccine (MRC-5 Cell) humans aged 10-20 years old;   Biological: 2.5IU/ml rabies vaccine (MRC-5 Cell) in humans aged 21-60 years old;   Biological: 2.5IU/ml rabies vaccine (MRC-5 Cell) in humans(from 10-20 years old);   Biological: 2.5IU/ml rabies vaccine (MRC-5 Cell) in humans(from 21-60 years old)
6 Not yet recruiting Prospective Cohort Study to Evaluate Safety/Immunogenicity of Butantan Influenza Vaccine in Healthy Adults/Elderly
Condition: Influenza
Intervention: Biological: Butantan Fragmented Inactivated Trivalent Influenza Vaccine
7 Not yet recruiting A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)
Condition: Hepatitis E
Intervention: Biological: Recombinant Hepatitis E Vaccine (Escherichia Coli)
8 Not yet recruiting Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine
Condition: Dengue
Intervention: Biological: Dengue 1,2,3,4 (Attenuated) Vaccine
9 Recruiting Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine
Condition: Meningitis
Interventions: Biological: MCV-ACYW135 Vaccine Group;   Biological: MPV-ACYW135 Vaccine Group;   Biological: MPV-A Vaccine Group;   Biological: MCV-AC Vaccine Group;   Biological: Hib Vaccine Group
10 Recruiting Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children
Condition: Immune Response to MMR Vaccine
Intervention: Biological: MMR vaccine
11 Unknown  Assessment of Needle-free Disposable-syringe Jet Injector (DSJI) ID Dose-sparing of Pandemic A H1N1 Influenza Vaccine
Condition: Influenza
Intervention: Biological: 2012 trivalent influenza vaccine
12 Recruiting Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine
Condition: Meningitis
Interventions: Biological: Minhai Bio;   Biological: Hualan Bio
13 Recruiting VZV Vaccine for Hematopoietic Stem Cell Transplantation
Condition: Varicella Zoster Infection
Interventions: Biological: Zostavax;   Biological: Normal Saline
14 Unknown  Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients
Conditions: High Risk HLA-A2+ Melanoma;   Metastatic Disease
Intervention: Biological: Melanoma vaccine modified to express HLA A2/4-1BB ligand
15 Not yet recruiting Vivotif Release Titers (USA)
Condition: Typhoid Fever
Intervention: Biological: Vivotif
16 Recruiting The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination
Condition: Varicella
Interventions: Biological: HBV-3;   Biological: HBV-6;   Biological: varicella-3;   Biological: varicella-6
17 Recruiting Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants
Conditions: Immunogenicity;   Reactogenicity
Intervention: Biological: Trivivac vaccine
18 Unknown  Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients
Conditions: HIV-1 Infection;   Cancer;   Immunosuppression
Intervention: Other: serologic testing
19 Recruiting Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Small Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Recurrent Cervical Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Interventions: Biological: Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001;   Other: Laboratory Biomarker Analysis
20 Recruiting Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults
Condition: Influenza, Human
Interventions: Drug: Intanza;   Drug: Vaxigrip

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years